About Stembio
Stembio is a Healthcare company based in Istanbul (Turkey) founded in 2020, and was acquired by Koc Holding in September 2024. Provider of human cell and tissue processing, storage, and clinical supply. Stembio offers products and services including EXOSTEM, STEMBIOCELL, STEMCORD, STEMTISSUE, and STEMANIMA. Its focus areas include Biopharma Outsourcing and Diversified.
Company details
Stembio was established in 2020 in Istanbul, Turkey, within the biotechnology sector focused on regenerative medicine. Human-derived cells and tissues are processed through specialized methods, including cryopreservation and quality control. Products are stored for accessibility and formatted for clinical applications. Services encompass cellular therapies, cord blood banking, tissue grafts, exosomes from mesenchymal stem cells, gene therapies, and aesthetic treatments.
- Headquarters Istanbul, Turkey
- Stage Acquired
- SectorsHealthcare
- Website stembio.com.tr
- Social LinkedIn X Facebook Instagram
- Acquired by Koc Holding (Sep 2024)
- Investors
- Acquired byKoc Holding
(Sep 2024)
Products & Services of Stembio
Stembio offers a comprehensive portfolio of products and services, including EXOSTEM, STEMBIOCELL, STEMCORD, STEMTISSUE, and STEMANIMA.
Provides exosomes from stem cells for medical treatments.
Produces and banks cellular products for therapies.
Handles autologous and allogeneic cord blood storage.
Manages human tissue grafts for medical applications.
Offers tissue and cellular products for animal treatments.
Provides products for esthetic and skin regeneration.
Delivers gene-based treatments for health conditions.
Supplies devices and services for regenerative applications.
Investors in Stembio
Stembio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Koc Holding.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are managed across energy, automotive, and finance sectors. | 1926 | koc.com.tr | Istanbul, Turkey |
Investor details for Stembio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Stembio
2 dated milestones of Stembio across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Stembio is founded.
- Exit Acquired by Koc Holding.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Stembio
Complete news archive for Stembio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stembio
Stembio was founded in 2020.
Stembio is headquartered in Istanbul, Turkey.
Stembio was established in 2020 in Istanbul, Turkey, within the biotechnology sector focused on regenerative medicine. Human-derived cells and tissues are processed through specialized methods, including cryopreservation and quality control. Products are stored for accessibility and formatted for clinical applications. Services encompass cellular therapies, cord blood banking, tissue grafts, exosomes from mesenchymal stem cells, gene therapies, and aesthetic treatments.
Stembio offers EXOSTEM, STEMBIOCELL, STEMCORD, STEMTISSUE, and 4 more products and services.
Stembio has 1 investor. Key investors include Koc Holding.
Yes. Stembio was acquired by Koc Holding in September 2024.